Learn how to manage psoriatic arthritis and psoriasis simultaneously with the right medication and treatment plan. Discover ...
The U.S. Food and Drug Administration has approved Johnson & Johnson's Icotyde (icotrokinra), an interleukin-23 (IL-23) ...
New oral psoriasis treatment Icotyde shows superior results over injectables, delivering clear skin with a safe, once-daily ...
Johnson & Johnson and Protagonist Therapeutics are countering the swarm of injectable biologics that have long dominated the ...
The company said the FDA approved Icotyde to treat moderate to severe plaque psoriasis in adults and pediatric patients 12 ...
A high proportion of patients with moderate to severe plaque psoriasis achieved long-term on-treatment remission for 3 years with bimekizumab, according to a poster presentation at Winter Clinical ...
When you have psoriasis — a skin disease that typically causes thick, itchy, scaly, or discolored patches of skin — finding a treatment that works for you can be a challenge. Luckily, there are more ...
Johnson & Johnson won U.S. approval for a daily psoriasis pill that rivals the benefits of injectable medicines and could ...
Psoriasis plaques have a stubborn habit of returning to the exact same patches of skin, even after months or years of ...